EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CYTK: Cytokinetics

26 Jun 26 08:52
LAST:

81.57

CHANGE:
 0.78		OPEN:
81.32		HIGH:
81.57		ASK:
10.15		VOLUME:
884
CHG(%):
0.97		PREV:
80.79		LOW:
80.65		BID:
6.61		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Jun 2681.3281.5780.6581.57884
25 Jun 2680.8482.9580.3780.802.39M
24 Jun 2680.5382.8379.1281.202.43M
23 Jun 2678.9980.4078.2780.012.08M
22 Jun 2680.0080.8078.3679.172.89M
18 Jun 2679.4180.1577.1478.783.55M
17 Jun 2675.8079.3075.7578.113.34M
16 Jun 2673.0077.0072.1575.213.97M
15 Jun 2670.1571.3868.8471.381.01M
12 Jun 2669.7471.2569.0670.151.29M

PROFILE

Name:Cytokinetics
About:Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It also develops CK- 089, a fast skeletal muscle troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase II clinical trial; and aficamten, a novel, oral, small molecule cardiac myosin inhibitor which is in Phase III clinical trial discovered for the treatment of hypertrophic cardiomyopathy. It has a strategic alliance with Ji Xing Pharmaceuticals Limited; and a collaboration and license agreement for the development and commercialization of aficamten in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Website:https://www.cytokinetics.com
CUSIP:23282W100
CIK:0001061983
ISIN:US23282W6057
FIGI:BBG000F0R4N9
LEI:549300BE5DY1HW7IHA64

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-11.41 
Forward P/E:-13.34 
PEG Ratio:0.79 
Price to Sales:88.75 
Price to Book:-12.27 
Profit Margin:-17.37 
Operating Margin:-1.67 
Return on Assets:-0.25 
Return on Equity:4.35 
EPS Ratio:-6.54 
Revenue:85.74M 
Shares:123.16M 
Market Cap:10.046B 

TECHNICAL INDICATORS

MA5:80.371.5%
MA10:77.555.2%
MA20:74.209.9%
MA50:72.4012.7%
MA100:68.1619.7%
MA200:64.4526.6%
STO9:80.12 
STO14:85.52 
RSI14:72.71 
WPR14:-3.89 
MTM14:12.75
ROC14:0.19 
ATR:3.19 
Week High:82.951.7%
Week Low:78.274.2%
Month High:82.951.7%
Month Low:66.6326.6%
Year High:82.951.7%
Year Low:32.66149.8%
Volatility:7.65 

RECENT SPLITS

Date Ratio
25 Jun 20131-6